Rockville, SOUTH%20CAROLINA2 Active Studies

Ankylosing Spondylitis Clinical Trials in Rockville, SOUTH%20CAROLINA

Find 2 actively recruiting ankylosing spondylitis clinical trials in Rockville, SOUTH%20CAROLINA. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
160
Enrolling

Recruiting Ankylosing Spondylitis Studies in Rockville

About Ankylosing Spondylitis Clinical Trials in Rockville

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 2 ankylosing spondylitis clinical trials recruiting participants in Rockville, SOUTH%20CAROLINA. These studies are seeking a combined 160 participants. Research is being sponsored by Stamford Pharmaceuticals, Inc., Oruka Therapeutics, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Rockville — FAQ

Are there ankylosing spondylitis clinical trials in Rockville?

Yes, there are 2 ankylosing spondylitis clinical trials currently recruiting in Rockville, SOUTH%20CAROLINA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Rockville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Rockville research site will contact you about next steps.

Are clinical trials in Rockville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Rockville studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 2 active trials in Rockville are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated March 2, 2026 from ClinicalTrials.gov